Clinical Gastroenterology and Hepatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

From Hirschowitz to 2023: Modern Endoscopy and Beyond
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 4, 2023 Category: Gastroenterology Authors: Allison R. Schulman, Joel D. Howell Tags: Comment From the Editor Source Type: research

Expanding role of gastroenterology in the staging of digestive neuroendocrine tumors: updates from the ajcc version 9 cancer staging system
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 4, 2023 Category: Gastroenterology Authors: Phillip S. Ge, Chanjuan Shi, Elliot Asare, Mary Kay Washington, Dermot O ’Toole Tags: Comment From the Editor Source Type: research

Mesalazine-Induced Obstructive Intrahepatic and Extrahepatic Bile Duct Inflammation Mimicking Cholangiocarcinoma
A 22-year-old man with ulcerative colitis was started on mesalazine slow-release tablets 2 grams twice daily and was hospitalized 3 months later for a 9-day history of jaundice, epigastric pain, nausea, vomiting, low-grade fever, and coughing. He had discontinued mesalazine 4 days before and received no other medications. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 3, 2023 Category: Gastroenterology Authors: Nicolai Vad, Yousef J.W. Nielsen, Casper Steenholdt Tags: Images and Videos Source Type: research

Mesalazine-induced obstructive intra- and extra-hepatic bile duct inflammation mimicking cholangiocarcinoma
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 3, 2023 Category: Gastroenterology Authors: Nicolai Vad, Yousef JW. Nielsen, Casper Steenholdt Tags: Images and Videos Source Type: research

The colorectal cancer enigma and early life exposures
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 3, 2023 Category: Gastroenterology Authors: Caitlin C. Murphy, Piera M. Cirillo, Nickilou Y. Krigbaum, Barbara A. Cohn Tags: Editorial Source Type: research

Lack of Effectiveness of Computer Aided Detection for Colorectal Neoplasia: A Systematic Review and Meta-analysis of Non-Randomized Studies
Benefits of computer-aided detection (CADe) in detecting colorectal neoplasia were shown in many randomized trials where endoscopists ’ behavior was strictly controlled. However, the effect of CADe on endoscopists’ performance in less-controlled setting is unclear. This systematic review and meta-analyses were aimed at clarifying benefits and harms of using CADe in real-world colonoscopy. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 3, 2023 Category: Gastroenterology Authors: Harsh K. Patel, Yuichi Mori, Cesare Hassan, Tommy Rizkala, Dhruvil K. Radadiya, Piyush Nathani, Sachin Srinivasan, Masashi Misawa, Roberta Maselli, Giulio Antonelli, Marco Spadaccini, Antonio Facciorusso, Kareem Khalaf, Davide Lanza, Giacomo Bonanno, Doug Source Type: research

Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn ’s Disease Activity
The operating properties of histologic indices for evaluating Crohn ’s disease (CD) activity are poorly characterized. We assessed the reliability and responsiveness of existing histologic indices/items used in CD and ulcerative colitis (UC), in addition to 3 novel items, and developed exploratory ileal, colonic, and colonic-ileal CD instruments. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 3, 2023 Category: Gastroenterology Authors: Virginia Solitano, David F. Schaeffer, Malcolm Hogan, Niels Vande Casteele, Rish K. Pai, Guangyong Zou, Reetesh K. Pai, Claire E. Parker, Julie R émillard, Britt Christensen, Silvio Danese, Laurent Peyrin-Biroulet, Remo Panaccione, Bruce E. Sands, Geert Source Type: research

Unusual Villiform Re-epithelialization in Barrett's Esophagus Following Endoscopic Treatment
A 57-year-old male patient with a history of high-grade dysplasia and intramucosal carcinoma in the context of Barrett's esophagus, treated with several endoscopic mucosal resections and radiofrequency ablation (RFA) procedures, presented for a follow-up gastroscopy. The endoscopic assessment revealed an unusual finding in the esophagus. The Barrett's segment, which had been previously treated, now exhibited a very fine villiform appearance (Figure  A, Video) with absence of the typical mucosal pattern when viewed under virtual chromoendoscopy (Figure B). (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 1, 2023 Category: Gastroenterology Authors: Kareem Khalaf, Katarzyna M. Pawlak, Gary R. May Tags: Image and Videos Source Type: research

Reply
In this study, we found that older adults with digestive diseases were more likely to rate their health as poor or fair, especially those individuals who experienced loneliness and depression. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 1, 2023 Category: Gastroenterology Authors: Shirley Cohen-Mekelburg, Brooke Kenney, Akbar K. Waljee Tags: Letter to the Editor Source Type: research

Unusual Villiform Re-epithelialisation in Barrett's Esophagus following Endoscopic Treatment
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 1, 2023 Category: Gastroenterology Authors: Kareem Khalaf, Katarzyna M. Pawlak, Gary R. May Tags: Images and Videos Source Type: research

Accuracy of the enhanced liver fibrosis test in patients with type 2 diabetes mellitus and its clinical implications
The diagnostic performance of the Fibrosis-4 (FIB-4) index and nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS) is poor in patients with type 2 diabetes mellitus (T2DM). We determined the usefulness of the enhanced liver fibrosis (ELF) test in patients with T2DM. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 1, 2023 Category: Gastroenterology Authors: Taeang Arai, Hirokazu Takahashi, Yuya Seko, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Toshihide Shima, Hideki Fujii, Asahiro Morishita, Kazuhito Kawata, Kengo Tomita, Miwa Kawanaka, Yuichi Yoshida, Tadashi Ikegami, Source Type: research

Psychosocial Factors and Self-Reported Health Status: A Reply to He, et al.
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 1, 2023 Category: Gastroenterology Authors: Shirley Cohen-Mekelburg, Brooke Kenney, Akbar K. Waljee Tags: Letter to the Editor Source Type: research

Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 1, 2023 Category: Gastroenterology Authors: Diego Anazco, Sima Fansa, Maria Daniela Hurtado, Michael Camilleri, Andres Acosta Tags: Research Letter Source Type: research

EXPLORing the Therapeutic Ceiling in Crohn ’s Disease: Will Combination Pave the Way?
There are numerous synonyms for explorer including: adventurer, pathfinder, pioneer, seeker, experimenter, pilgrim, searcher, and traveler. The investigators in the EXPLORER trial sought to improve the “efficacy ceiling” for treating Crohn’s disease (CD) by venturing into combination therapy by combining 3 semi-independent mechanisms of action (MOAs) that, individually, have demonstrable efficacy.1 Both vedolizumab and adalimumab are biological drugs approved to induce and maintain remission , whereas (parenteral) methotrexate has not been evaluated as an independent induction agent. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - November 30, 2023 Category: Gastroenterology Authors: Joana Torres, Stephen B. Hanauer Tags: Editorial Source Type: research

What the New Definition of MASLD Left Behind: Dual Etiology With Viral Hepatitis
We read with great interest the published recently article about the prevalence of steatotic liver diseases by Kalligeros et  al.1 Undoubtedly, the nomenclature for fatty liver disease was in need of revision. In 2020, Eslam et al2 introduced the metabolic dysfunction–associated fatty liver disease (MAFLD) nomenclature, which subsequently was widely accepted and implemented by various national and pan-national societi es. In practice and research, MAFLD has proven superior to the previous name, nonalcoholic fatty liver disease (NAFLD), in several respects. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - November 30, 2023 Category: Gastroenterology Authors: Yasser Fouad, Faisal Sanai, Mohamed Alboraie, Ming-Hua Zheng Tags: Letter to the Editor Source Type: research